| 12:18 | REDX | Result of GM, Cancellation of Admission to Trading | RNS |
| 18.04.2024 07:00 | REDX | Share Purchases by a Director | RNS |
| 12.04.2024 07:00 | REDX | Share Purchase by a Director | RNS |
| 10.04.2024 07:00 | REDX | Update on Broking Arrangements | RNS |
| 08.04.2024 15:32 | REDX | TR-1: Notification of major holdings | RNS |
| 02.04.2024 12:15 | REDX | Redx Pharma plummets on plans to delist from AIM | Alliance |
| 02.04.2024 10:50 | BELL, REDX, 88E | AIM WINNERS & LOSERS: 88 Energy finds oil at Hickory-1; Redx to delist | Alliance |
| 02.04.2024 07:00 | REDX | Proposed Cancellation of Admission to Trading | RNS |
| 14.03.2024 11:27 | REDX | Result of AGM | RNS |
| 06.03.2024 07:00 | REDX | Redx to Exhibit Three Posters at AACR | RNS |
| 28.02.2024 07:00 | REDX | First Participant Dosed in Phase 1 Trial of RXC008 | RNS |
| 26.02.2024 07:00 | REDX | Redx to Present at Cowen Health Care Conference | Reach |
| 23.02.2024 07:00 | REDX | New Grant of Options | RNS |
| 16.02.2024 16:50 | REDX | Notice of AGM | RNS |
| 14.02.2024 09:34 | REDX | IN BRIEF: Redx Pharma clarifies not currently pursuing US listing | Alliance |
| 14.02.2024 07:00 | REDX | Statement re Press Report | RNS |
| 08.02.2024 13:02 | REDX | TR-1: Notification of major holdings | RNS |
| 07.02.2024 11:08 | REDX | Redx Pharma shares skyrocket on deal to sell inhibitor program | Alliance |
| 07.02.2024 09:29 | HE1, REDX | AIM WINNERS & LOSERS: Verditek falls on cash shell plans | Alliance |
| 07.02.2024 07:00 | REDX | Redx announces sale of KRAS inhibitor program | RNS |
| 15.12.2023 21:09 | DCTA, AGY, BRH | EARNINGS AND TRADING: Redx full year revenue tumbles; loss widens | Alliance |
| 15.12.2023 07:00 | REDX | Final Audited Results for Year Ended 30 September | RNS |
| 12.12.2023 07:00 | REDX | Notice of Preliminary Results | RNS |
| 09.11.2023 07:00 | REDX | Holdings in Company | RNS |
| 08.11.2023 13:58 | REDX | TR-1: Notification of major holdings | RNS |
| 08.11.2023 13:55 | REDX | TR-1: Notification of major holdings | RNS |
| 07.11.2023 08:10 | REDX | Admission of Subscription Shares and TVR | RNS |
| 06.11.2023 11:22 | REDX | Results of General Meeting | RNS |
| 06.11.2023 07:00 | REDX | Redx Unveils Preclinical Data from RXC009 | Reach |
| 30.10.2023 07:00 | REDX | Redx to present preclinical data on RXC009 at ASN | Reach |
| 18.10.2023 12:30 | REDX | Redx Pharma looks to progress portfolio after raising GBP14.1 million | Alliance |
| 18.10.2023 07:00 | REDX | Proposed Subscription to raise c.£14.1 million | RNS |
| 06.09.2023 10:45 | REDX | Confirmation of Directorate Change | RNS |
| 22.08.2023 07:00 | REDX | Directorate Change | RNS |
| 21.08.2023 10:29 | REDX, FAB | AIM WINNERS & LOSERS: Fulcrum Utility to leave AIM as loss widens | Alliance |
| 21.08.2023 09:33 | REDX | Redx Pharma says RXC007 receives orphan drug designation from US FDA | Alliance |
| 21.08.2023 07:00 | REDX | Zelasudil granted FDA Orphan Drug Designation | Reach |
| 10.07.2023 11:22 | REDX | Redx Pharma extends term of outstanding notes with two lenders to 2024 | Alliance |
| 10.07.2023 07:00 | REDX | Extension to Termination of Convertible Loan Notes | RNS |
| 03.07.2023 07:00 | REDX | Directorate Change | RNS |
| 30.06.2023 07:00 | REDX | New Grant of Options | RNS |
| 31.05.2023 07:00 | REDX | Redx to present at Jefferies Healthcare Conference | Reach |
| 17.05.2023 14:44 | REDX | Redx Pharma half-year loss doubles amid costs of failed Jounce merger | Alliance |
| 17.05.2023 07:00 | REDX | Interim Results for the Six Months Ended 31 March | RNS |
| 12.05.2023 09:51 | REDX | Discovery of Pirtobrutinib Recognised with Plaque | Reach |
| 11.05.2023 18:17 | REDX | IN BRIEF: Redx reports positive preclinical data for fibrosis drug | Alliance |
| 11.05.2023 07:00 | REDX | Presentation of RXC007 Preclinical Efficacy Data | Reach |
| 10.05.2023 15:45 | WOSG, TCAP, SMT | UK earnings, trading statements calendar - next 7 days | Alliance |
| 10.05.2023 07:00 | REDX | Notice of Interim Results | RNS |
| 03.05.2023 07:00 | REDX | Redx to Present at Keystone Symposia | Reach |
| 03.04.2023 18:05 | PXS, TGR, SLE | TRADING UPDATES: Redx confirms Jounce deal lapses, Tirupati seals deal | Alliance |
| 03.04.2023 07:01 | REDX | Proposed Business Combination Formally Lapsed | RNS |
| 03.04.2023 07:00 | REDX | Termination of Proposed Business Combination | RNS |
| 30.03.2023 08:36 | REDX | Form 8.5 (EPT/RI) - Redx Pharma plc | RNS |
| 27.03.2023 14:34 | REDX | Redx Pharma's bid to buy Jounce snubbed by Concentra's higher offer | Alliance |
| 27.03.2023 14:06 | REDX | Statement Following Jounce Announcement | RNS |
| 27.03.2023 14:00 | REDX | Statement re Merger Agreement | RNS |
| 24.03.2023 14:31 | REDX | Form 8.3 - Jounce Therapeutics, Inc | RNS |
| 22.03.2023 14:20 | REDX | Form 8.3 - Jounce Therapeutics, Inc | RNS |
| 20.03.2023 15:00 | REDX | Form 8.3 - Jounce Therapeutics, Inc | RNS |
| 20.03.2023 10:38 | REDX | Form 8.5 (EPT/RI) | RNS |
| 16.03.2023 09:48 | REDX | Form 8.5 (EPT/RI) | RNS |
| 15.03.2023 16:40 | REDX | Second Price Monitoring Extn | RNS |
| 15.03.2023 16:35 | REDX | Price Monitoring Extension | RNS |
| 15.03.2023 14:05 | REDX | Second Price Monitoring Extn | RNS |
| 15.03.2023 14:00 | REDX | Price Monitoring Extension | RNS |
| 15.03.2023 10:50 | REDX | Statement re: Jounce Therapeutics Press Release | RNS |
| 14.03.2023 11:45 | REDX | Result of Annual General Meeting | RNS |
| 10.03.2023 07:00 | REDX | Form 8.3 - Redx Pharma Plc | RNS |
| 09.03.2023 16:35 | REDX | Price Monitoring Extension | RNS |
| 09.03.2023 11:22 | REDX | Form 8 (OPD) - Jounce Therapeutics, Inc | RNS |
| 09.03.2023 11:15 | REDX | Form 8 (OPD) - Redx Pharma Plc | RNS |
| 09.03.2023 08:34 | REDX | Form 8.5 (EPT/RI) | RNS |
| 09.03.2023 07:00 | REDX | Form 8.3 - Redx Pharma plc | RNS |
| 08.03.2023 11:52 | REDX | Redx Pharma shares slide on RXC004 monotherapy blow | Alliance |
